Identification of circulating miRNA as early diagnostic molecular markers in malignant glioblastoma base on decision tree joint scoring algorithm

Authors:

Abstract
Purpose The lack of clinical markers prevents early diagnosis of glioblastoma (GBM). Many studies have found that circulating microRNAs (miRNAs) can be used as early diagnostic markers of malignant tumours. Therefore, the identification of novel circulating miRNA biomolecular markers could be beneficial to clinicians in the early diagnosis of GBM. Methods We developed a decision tree joint scoring algorithm (DTSA), systematically integrating significance analysis of microarray (SAM), Pearson hierarchical clustering, T test, Decision tree and Entropy weight score algorithm, to screen out circulating miRNA molecular markers with high sensitivity and accuracy for early diagnosis of GBM. Results DTSA was developed and applied for GBM datasets and three circulating miRNA molecular markers were identified, namely, hsa-miR-2278, hsa-miR-555 and hsa-miR-892b. We have found that hsa-miR-2278 and hsa-miR-892b regulate the GBM pathway through target genes, promoting the development of GBM and affecting the survival of patients. DTSA has better classification effect in all data sets than other classification algorithms, and identified miRNAs are better than existing markers of GBM. Conclusion These results suggest that DTSA can effectively identify circulating miRNA, thus contributing to the early diagnosis and personalised treatment of GBM.
Funding Information
  • National Nature Science Foundation of China (61801151)
  • China Postdoctoral Science Foundation (2019M651298)
  • Postdoctoral Foundation of Heilongjiang Province (LBH-Z18129, LBH-Z18187)
  • Natural Science Foundation of Heilongjiang Province (LH2021F053, LH2023H013)
  • the construction project of doctoral program in Traditional Chinese Medicine (Tibetan Medicine) in University of Tibetan Medicine (BSDJS-20-07)

This publication has 41 references indexed in Scilit: